Oncotarget

Priority Research Papers:

Cytosolic Hsp90α and its mitochondrial isoform Trap1 are differentially required in a breast cancer model

Evangelia Vartholomaiou, Marta Madon-Simon, Stéphane Hagmann, Guillaume Mühlebach, Wolfgang Wurst, Thomas Floss, Didier Picard _

PDF  |  HTML  |  Supplementary Files  |  Order a Reprint

Oncotarget. 2017; 8:17428-17442. https://doi.org/10.18632/oncotarget.15659

Metrics: PDF 564 views  |   HTML 1071 views  |   ?  


Abstract

Evangelia Vartholomaiou1,*, Marta Madon-Simon1,*, Stéphane Hagmann1, Guillaume Mühlebach1, Wolfgang Wurst2,3,4,5, Thomas Floss2 and Didier Picard1

1 Département de Biologie Cellulaire, Université de Genève, Sciences III, Genève, Switzerland

2 Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany

3 Deutsches Zentrum für Neurodegenerative Erkrankungen e. V., München, Germany

4 Munich Cluster for Systems Neurology, München, Germany

5 Technische Universität München-Weihenstephan, Neuherberg, Germany

* These authors have contributed equally to this work

Correspondence:

Didier Picard, email:

Keywords: Hsp90; Trap1; breast cancer; metastasis; mouse model

Received: January 12, 2017 Accepted: February 15, 2017 Published: February 23, 2017

Abstract

The Hsp90 family of molecular chaperones includes the cytosolic isoforms Hsp90α and Hsp90β, and the mitochondrial isoform Trap1. Hsp90α/β support a large number of client proteins in the cytoplasm and the nucleus whereas Trap1 regulates oxidative phosphorylation in mitochondria. Many of the associated proteins and cellular processes are relevant to cancer, and there is ample pharmacological and genetic evidence to support the idea that Hsp90α/β and Trap1 are required for tumorigenesis. However, a direct and comparative genetic test in a mouse cancer model has not been done. Here we report the effects of deleting the Hsp90α or Trap1 genes in a mouse model of breast cancer. Neither Hsp90α nor Trap1 are absolutely required for mammary tumor initiation, growth and metastasis induced by the polyoma middle T-antigen as oncogene. However, they do modulate growth and lung metastasis in vivo and cell proliferation, migration and invasion of isolated primary carcinoma cells in vitro. Without Hsp90α, tumor burden and metastasis are reduced, correlating with impaired proliferation, migration and invasion of cells in culture. Without Trap1, the appearance of tumors is initially delayed, and isolated cells are affected similarly to those without Hsp90α. Analysis of expression data of human breast cancers supports the conclusion that this is a valid mouse model highlighting the importance of these molecular chaperones.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 15659